- Onuoha A.C.1, Onuoha-Ojeamiren G.O.2, Adunbiola P.O.3, Abdullazeez M.I.4, Iweka F.K.5, Dada F.L.5, Uwuigbe C.O.6, Jimmy R.E.7, Emordi J.E.8
- DOI: 10.5281/zenodo.23911024
- GAS Journal of Clinical Medicine and Medical Research (GASJCMMR)
The atherogenic index of
plasma (AIP), calculated as log10 [triglyceride/high-density lipoprotein
cholesterol (HDL-C)], is a sensitive marker of atherogenic dyslipideamia, small
dense low-density lipoprotein particle size, and residual cardiovascular risk
beyond individual lipid parameters. Its role in hypertensive patients in Irrua
remains underexplored.
Objective: To determine the distribution of AIP and its
relationship with blood pressure (BP) control among hypertensive patients in
Irrua, Southern Nigeria.
Method: This was a hospital-based, cross-sectional study of
300 adult hypertensive patients (299 with complete lipid data for AIP
calculation) attending the Cardiology clinic of Irrua Specialist Teaching
Hospital, Edo State, Nigeria. Fasting lipid profile was measured and AIP
calculated as log10 (TG/HDL-C). AIP was categorized as low-risk (<0.11),
intermediate-risk (0.11-0.21), high-risk (>0.21). BP control was defined as
<140/90 mmHg in accordance with the European Society of Cardiology/European
Society of Hypertension guidelines.
Results: The mean AIP was -0.04 + 0.26. A low-risk AIP was
found in 75.3% of the patients, intermediate risk in 15.1% and high risk in
9.7%. Blood pressure control was poor and not significantly associated with AIP
category.
Conclusion: AIP was low in most hypertensives in Irrua, and was
not a strong discriminator of BP control. Routine lipid screening remains
important, but AIP alone should not guide BP management.
Keywords: Atherogenic Index of Plasma;
Blood Pressure Control; Hypertension; Dyslipideamia; Irrua; Nigeria

